Who owns the MTAC trademark?

The MTAC trademark is owned by Avilar Therapeutics, Inc..

What class is the MTAC trademark registered in?

The MTAC trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for MTAC?

The USPTO serial number for MTAC is 97139738.

What is the registration number for MTAC?

MTAC is registered under USPTO registration number 0.

Sealvo

Home Search: MTACMTAC #97139738

Back

Updated Sep 29, 2026·20 searches this week

View on USPTO TSDR Find similar marks

MTA

USPTO Trademark Record

PENDING

MTAC

SN 97139738·Reg 0·Filed Nov 23, 2021

Owner Avilar Therapeutics, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

MTAC (Serial No. 97139738), Registration No. 0, is a pending US trademark filed on Nov 23, 2021 by Avilar Therapeutics, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

Conflict Analysis

Full conflict analysis for MTAC (SN 97139738) against the USPTO database with detailed risk factor explanations. AI-powered — takes ~1-2 min.

Mark Intelligence

MTAC (Reg. #0) is a pending US trademark that was filed in 2021 and is currently under USPTO examination. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Nov 23, 2021

SERIAL

97139738

REG#

REGISTERED

Dec 31, 1969

Filing Information

StatusPENDING

Filing DateNov 23, 2021

Serial Number97139738

Registration No.0

Registration DateDec 31, 1969

Status DateDec 08, 2025

Published for OppositionApr 11, 2023

Filing Basis & Declarations

Standard Characters ClaimedTrademark

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

40 events

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Dec 09, 2025

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Dec 08, 2025

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 5 GRANTED

Dec 08, 2025

SOU EXTENSION 5 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Sep 15, 2025

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU EXTENSION 4 GRANTED

Jun 08, 2025

SOU EXTENSION 4 GRANTED

SOU TEAS EXTENSION RECEIVED

Jun 04, 2025

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 4 FILED

Jun 03, 2025

SOU EXTENSION 4 FILED

SOU EXTENSION 5 FILED

Jun 03, 2025

SOU EXTENSION 5 FILED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Dec 06, 2024

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU EXTENSION 3 GRANTED

Dec 06, 2024

SOU EXTENSION 3 GRANTED

SOU TEAS EXTENSION RECEIVED

Dec 05, 2024

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 3 FILED

Dec 05, 2024

SOU EXTENSION 3 FILED

DIVISIONAL REQUEST RECEIVED

Jun 20, 2024

DIVISIONAL REQUEST RECEIVED

DIVISIONAL PROCESSING COMPLETE

Jun 20, 2024

DIVISIONAL PROCESSING COMPLETE

SOU EXTENSION 2 GRANTED

Jun 20, 2024

SOU EXTENSION 2 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jun 20, 2024

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Jun 10, 2024

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Jun 10, 2024

CASE ASSIGNED TO INTENT TO USE PARALEGAL

SOU TEAS EXTENSION RECEIVED

May 06, 2024

SOU TEAS EXTENSION RECEIVED

TEAS STATEMENT OF USE RECEIVED

May 06, 2024

TEAS STATEMENT OF USE RECEIVED

TEAS REQUEST TO DIVIDE RECEIVED

May 06, 2024

TEAS REQUEST TO DIVIDE RECEIVED

SOU EXTENSION 2 FILED

May 06, 2024

SOU EXTENSION 2 FILED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Dec 06, 2023

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Dec 04, 2023

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 1 FILED

Dec 04, 2023

SOU EXTENSION 1 FILED

SOU EXTENSION 1 GRANTED

Dec 04, 2023

SOU EXTENSION 1 GRANTED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Jun 06, 2023

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Apr 11, 2023

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Apr 11, 2023

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Mar 22, 2023

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Mar 08, 2023

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Mar 03, 2023

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Mar 03, 2023

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Mar 03, 2023

TEAS/EMAIL CORRESPONDENCE ENTERED

NON-FINAL ACTION WRITTEN

Sep 06, 2022

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Sep 06, 2022

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Sep 06, 2022

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Sep 03, 2022

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Nov 29, 2021

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Nov 26, 2021

NEW APPLICATION ENTERED

Other Marks by Avilar Therapeutics, Inc.

Additional USPTO filings from the same owner.

MTA

MTAC

97978308

Avilar Therapeutics, Inc.

REGISTERED

AVI

AVILAR THERAPEUTICS

97263555

Avilar Therapeutics, Inc.

REGISTERED

AVI

AVITAC

97813070

Avilar Therapeutics, Inc.

PENDING

XTA

XTAC

97813121

Avilar Therapeutics, Inc.

PENDING

Other Marks by Brent R. Bellows

Additional USPTO filings handled by the same attorney of record.

TEL

TELLENIAL

98091979

REGISTERED

KEC

KECTIL AI YOUTH NETWORK

98362116

REGISTERED

MKF

MKFF AI YOUTH NETWORK

98362191

REGISTERED

AIC

AI CONNECTED YOUTH LEADERS

98362213

REGISTERED

MTAC

Run a conflict check

Other Marks by Avilar Therapeutics, Inc.

Other Marks by Brent R. Bellows

Get pre-filing clearance

Search 15M+ trademarks

Resources

Company